This chapter delves into the complex world of genetic testing, highlighting the limitations of current methods, the challenges faced by companies like 23andMe in providing accurate health risk assessments, and the uncertainty surrounding the future of genetic testing. It discusses the high costs associated with treating detected genetic variants, the transition towards personalized genetic testing, and the impact of privacy concerns and data breaches on consumer perception and sales.
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Intelligence Senior Retail Analysts Jennifer Bartashus discusses Walmart successfully growing operating income faster than sales, a trend likely to continue in fiscal 2Q as the company reaps benefits from a changing business mix. Bloomberg News Health Care Reporter Kristen V. Brown shares the details of her Businessweek Magazine cover story 23andMe's Fall Exposes DNA Testing as More Gimmick Than Remedy. Durga Malladi, Head of AI at Qualcomm, talks about the rise of on-device artificial intelligence. And we Drive to the Close with Ryan Kelley, CIO & Portfolio Manager at Hennessy Funds.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.